Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization Philippe Kolh, MD, PhD, Paul Kurlansky,

Slides:

Advertisements

Similar presentations

New ESC/EACTS guidelines on myocardial revascularisation Indications for coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention.

Advertisements

The “occasional open heart surgeon” revisited

Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts Robert H. Habib, PhD,

Late survival in abdominal aortic aneurysm patients: The role of selective myocardial revascularization on the basis of clinical symptoms Martha M. Reigel,

Comparison of radial artery patency according to proximal anastomosis site: Direct aorta to radial artery anastomosis is superior to radial artery composite.

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Technological innovation in cardiothoracic surgery: A pragmatist's approach Pedro J. del Nido, MD The Journal of Thoracic and Cardiovascular Surgery

Myocardial bridging over the left anterior descending: Myotomy, bypass, or both? Chigozirim N. Ekeke, BS, Stephen Noble, MD, Ernest Mazzaferri, MD, Juan.

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Standardizing definitions for hybrid coronary revascularization

The present day potential role of fractional flow reserve–guided coronary artery bypass graft surgery Filip Casselman, MD, PhD, FETCS, Johan Van der.

Manesh R. Patel, MD, FACC, Gregory J

Short- and intermediate-term outcomes of hybrid coronary revascularization for double- vessel disease Nirav C. Patel, MD, Jonathan M. Hemli, MD, Michael.

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

CD133+ cells: How could they have an IMPACT?

Peter K. Smith, MD The Annals of Thoracic Surgery

The surgical and interventional hybrid era: Experiences from China

Building a bioartificial heart: A 3-song saga

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc, FRCSC, FACP, FACC

Juan A. Crestanello, MD, Richard C. Daly, MD

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Progressive improvement of myocardial perfusion after off-pump revascularization with bilateral internal thoracic arteries: Comparison of early versus.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Michael E. Halkos, MD, MSc, Henry A

Percutaneous coronary intervention of the left main coronary artery in a patient with extrinsic compression caused by massive pulmonary artery enlargement

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact Jack V. Tu, MD, PhD, Anam M. Khan,

Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years

A protocol-driven approach to early extubation after heart surgery

For everything there is a season

Survival probability loss from percutaneous coronary intervention compared with coronary artery bypass grafting across age groups Umberto Benedetto,

To bypass or stent? The changing rules of an advancing game

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

A fate worse than death Jennifer S. Lawton, MD

Using bilateral internal thoracic arteries—just do it

Treatment of deep sternal wound infections after coronary artery bypass grafting by means of injection of platelet gel: An evolving technology Erez Kachel,

Shunt right or left? Decision 2016

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

Commentary: “Isn't cardiac surgery a team sport?”

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

The continuing challenge of congenital heart disease in China

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Apples remain apples NO matter what

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

Preoperative PFTs: The answer is blowing in the wind

European Society of Thoracic Surgeons preoperative mediastinal staging guidelines: From face validity to external validity Alessandro Brunelli, MD The.

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Zipping up after a median sternotomy: Are we at the end of the wire?

Commentary: Radial artery and bilateral mammary arteries in coronary artery bypass grafting: How much is too much? Derrick Y. Tam, MD, Stephen E. Fremes,

Presentation transcript:

Transatlantic editorial: A comparison between European and North American guidelines on myocardial revascularization Philippe Kolh, MD, PhD, Paul Kurlansky, MD, Jochen Cremer, MD, PhD, Jennifer Lawton, MD, Matthias Siepe, MD, Stephen Fremes, MD, MSc The Journal of Thoracic and Cardiovascular Surgery Volume 152, Issue 2, Pages 304-316 (August 2016) DOI: 10.1016/j.jtcvs.2016.04.053 Copyright © 2016 The American Association for Thoracic Surgery, The Society of Thoracic Surgeons, and The Authors Terms and Conditions

Figure 1 Percutaneous coronary intervention or coronary artery bypass graft surgery in stable coronary artery disease without left main coronary artery involvement. a>50% stenosis and proof of ischemia, >90% stenosis in two angiographic views or fractional flow reserve <0.80. bCABG is the preferred option in most patients unless patients' comorbidities or specificities deserve discussion by the Heart Team. According to local practice (time constraints and workload), direct transfer to CABG may be allowed in these low-risk patients, when formal discussion in a multidisciplinary team is not required. CABG, Coronary artery bypass grafting; LAD, left anterior descending; PCI, percutaneous coronary intervention. (Adapted from ESC/EACTS Guidelines on Myocardial Revascularization 2010; reproduced from reference 17 with permission of Oxford University Press (UK) © European Society of Cardiology, www.escardio.org/guidelines.) The Journal of Thoracic and Cardiovascular Surgery 2016 152, 304-316DOI: (10.1016/j.jtcvs.2016.04.053) Copyright © 2016 The American Association for Thoracic Surgery, The Society of Thoracic Surgeons, and The Authors Terms and Conditions

Figure 2 Percutaneous coronary intervention or coronary artery bypass graft surgery in stable coronary artery disease with left main coronary artery involvement. a>50% stenosis and proof of ischemia, >70% stenosis in two angiographic views or fractional flow reserve <0.80. bPreferred option in general. According to local practice (time constraints and workload), direct decision may be taken without formal multidisciplinary discussion, but preferably with locally agreed protocols. CABG, Coronary artery bypass grafting; PCI, percutaneous coronary intervention. (Adapted from ESC/EACTS Guidelines on Myocardial Revascularization 2010; reproduced from reference 17 with permission of Oxford University Press (UK) © European Society of Cardiology, www.escardio.org/guidelines.) The Journal of Thoracic and Cardiovascular Surgery 2016 152, 304-316DOI: (10.1016/j.jtcvs.2016.04.053) Copyright © 2016 The American Association for Thoracic Surgery, The Society of Thoracic Surgeons, and The Authors Terms and Conditions

A treatment algorithm for PCI or CABG in stable CAD without LM involvement. The Journal of Thoracic and Cardiovascular Surgery 2016 152, 304-316DOI: (10.1016/j.jtcvs.2016.04.053) Copyright © 2016 The American Association for Thoracic Surgery, The Society of Thoracic Surgeons, and The Authors Terms and Conditions